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Abstract
Background: The Ada-dependent adaptive response system in Escherichia coli is important for
increasing resistance to alkylation damage. However, the global transcriptional and translational
changes during this response have not been reported. Here we present time-dependent global gene
and protein expression profiles following treatment with methyl methanesulfonate (MMS) in E. coli
W3110 and its ada mutant strains.
Results: Transcriptome profiling showed that 1138 and 2177 genes were differentially expressed
in response to MMS treatment in the wild-type and mutant strains, respectively. A total of 81
protein spots representing 76 nonredundant proteins differentially expressed were identified using
2-DE and LC-MS/MS. In the wild-type strain, many genes were differentially expressed upon long-
exposure to MMS, due to both adaptive responses and stationary phase responses. In the ada
mutant strain, the genes involved in DNA replication, recombination, modification and repair were
up-regulated 0.5 h after MMS treatment, indicating its connection to the SOS and other DNA
repair systems. Interestingly, expression of the genes involved in flagellar biosynthesis, chemotaxis,
and two-component regulatory systems related to drug or antibiotic resistance, was found to be
controlled by Ada.
Conclusion: These results show in detail the regulatory components and pathways controlling
adaptive response and how the related genes including the Ada regulon are expressed with this
response.
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Background
Alkylation damage to DNA occurs when cells encounter
alkylating agents in the environment or when active
alkylators are generated by nitrosation of amino acids in
metabolic pathways [1,2]. The DNA damage by alkylating
agents results in disruption of DNA function and cell
death. The alkylating agents represent an abundant class
of chemical DNA damaging agent in our environment
and are toxic, mutagenic, teratogenic and carcinogenic.
Since we are continuously exposed to alkylating agents,
and since certain alkylating agents are used for cancer
chemotherapy, it is important to understand exactly how
cells respond to these agents. Alkylating agents are com-
monly used anti-cancer drugs and remain important for
the treatment of several types of cancer [3,4]. Alkylating
drugs are mostly methylating agents (e.g. temozolomide
and streptozotocin, an antibiotic) or chloroethylating
agents (e.g. carmustine, lomustine and fotemustine) [5].
The efficacies of these drugs are strongly modulated by
DNA repair process. Thus, thorough understanding and
controlling of the repair processes will allow development
of new therapies by protecting normal tissues or by poten-
tiating effects in the target tissues.
To cope with DNA alkylation damage, cells have evolved
genes that encode proteins with alkylation-specific DNA
repair activities. It is notable that these repair systems are
conserved from bacteria to humans [6]. In Escherichia coli,
cells exposed to a low concentration of an alkylating
agent, such as N-methyl-N'-nitro-N-nitrosoguanidine
(MNNG) or methyl methanesulfonate (MMS), show a
remarkable increase in resistance to both the lethal and
mutagenic effects of subsequent high-level challenge
treatments with the same or other alkylating agents [7,8].
This increased resistance has been known as "adaptive
response" to alkylation damage in DNA.
To date, four genes have been identified as components of
this response, ada,  alkA,  alkB and aidB. The ada  gene
encodes the Ada protein, which has the dual function of a
transcriptional regulator for the genes involved in the
adaptive response, and a methyltransferase that demethyl-
ates two methylated bases (O6meG and O4meT) and
methylphosphotriesters produced by methylating agents
in the sugar phosphate backbone [6,9]. When methylated
at Cys-69, Ada is converted to a potent activator for the
transcription of the ada and alkA, alkB and aidB genes by
binding to a consensus sequence referred to as an "Ada
box" present in the promoter. The alkA gene encodes a gly-
cosylase that repairs several different methylated bases,
and the alkB gene, which forms a small operon with the
ada gene, is required for error-free replication of methyl-
ated single-stranded DNA [10]. The aidB gene encodes the
protein that appears to detoxify nitrosoguanines and to
reduce the level of methylation by alkylating agents. Early
studies have shown that the expression of the ada-alkB
operon, alkA and aidB genes is positively controlled by
Ada protein, after it interacts with methylated DNA [11-
14]. In contrast, Ada protein also plays a pivotal role in the
negative modulation of its own synthesis, and conse-
quently, in the down-regulation of the adaptive response.
The carboxyl-terminus of Ada protein appears to be neces-
sary for this negative regulatory function; thus, Ada pro-
tein can act as both a positive and a negative regulator for
the adaptive response of E. coli to alkylating agents [13].
The transcriptional activity of E. coli Ada protein is also
directly regulated by posttranslational covalent modifica-
tion; however, the regulatory components and pathways
controlling the adaptive response have not been well stud-
ied.
Recent advances in functional genomics studies have facil-
itated understanding of global metabolic and regulatory
alterations caused by genotypic and/or environmental
changes. DNA microarray has proven to be a successful
tool for monitoring genome-wide expression profiles at
the mRNA level. Similarly, proteomics can be used to
compare changes in levels of many proteins under partic-
ular genetic and environmental conditions. Furthermore,
proteomic studies provide information on posttransla-
tional modifications, which cannot be obtained from
mRNA expression profiles; these have proven critical to
our understanding of proper physiological protein func-
tion, translocation, and subcellular localization. Ideally,
information obtained from these technologies needs to be
integrated to better understand the phenotypic character-
istics of the cell under a given condition [15]. Recently,
combined transcriptome and proteome approaches have
allowed large-scale analysis of biological systems at the
mRNA and protein levels, providing us with a wealth of
information that is useful in data-driven discovery [16-
19].
In this paper, we report the global expression changes in
the gene and protein levels of E. coli K-12 W3110 and ada
mutant strains in response to alkylating agents. In addi-
tion, the differences between the wild-type and mutant
strains without treatment of alkylating agents were charac-
terized at transcriptome and proteome levels. The analysis
of time- and strain-dependent adaptive responses
revealed the regulatory and physiological characteristics
of the Ada-dependent adaptive response in E. coli.
Results and discussion
Growth profiles of E. coli W3110 and ada mutant strains 
under MMS-treated and -untreated conditions
Growth of the ada  mutant strain was reduced in LB
medium without MMS addition according to culture time,
and reached the final OD600 of 3.48, which was about 1.5-
fold lower than that of the wild-type (Figure 1). In orderBMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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to induce adaptive responses that increase resistance to
alkylation damage to DNA, cells were treated with 0.04%
MMS at an OD600 of 0.4 [20]. As shown in Figure 1, the
growth of both strains gradually retarded following MMS
addition. The final OD600 of 3.70 and 2.22 were reached
at 11 h for the wild-type and the ada  mutant strains,
respectively, which were significantly lower than those of
the control cultures. However, there were no noticeable
differences in cell size and morphology between the ada
mutant and its parent strains. Growth of the ada mutant
strain was found to be additionally inhibited after the
MMS treatment. This indicates that the defect in the ada
gene negatively influences cell growth even under the nor-
mal condition, and especially the ada  product has an
important role in adaptive responses when alkylating
agents are present, as has been shown previously [21]. The
difference of growth between the strains will be discussed
later combined with transcriptome and proteome analy-
ses. It should be noted that the last sampling points are in
the middle of stationary phase for all strains with and
without MMS treatment, which becomes evident when
the growth curve is redrawn in log-scale.
Transcriptome and proteome profiles of E. coli W3110 in 
response to MMS
Transcriptome and proteome analyses were performed for
the samples taken at 0.5, 1.5 and 3.9 h following MMS
treatment for both MMS-treated and -untreated control
cultures, and the expression levels were compared. Those
genes and proteins which were differentially expressed by
greater than 2-fold or less than a half in MMS-treated cells
compared with the controls (MMS-untreated cells) were
considered to be meaningfully up- or down-regulated
ones by MMS treatment.
To find further functional characteristics of genes impli-
cated in adaptive response, differentially expressed genes
of known function were selected and classified according
to functional category [22] (Figure 2). At 0.5 h following
MMS treatment, 139 genes were found to be up-regulated,
while no gene was down-regulated. Proteome analysis
showed the induction of 17 protein spots in MMS treated
cultures (Figure 3, Additional file 1: Table S1). The most
strongly induced proteins were those involved in DNA
replication, recombination, modification and repair
(RecA and Mfd); cell process including adaptation and
protection (AhpF, HtpG, NfnB and YfiD); translation and
posttranslational modification (DsbA, InfB, ProS, RpsB,
ThrS and one isoform of Tsf); and others (Eda, GlpD,
RpoC, YjgF and YeaG). Interestingly, a different isoform of
elongation factor Ts (encoded by the tsf  gene) was
detected in the case of MMS-treated cells, the spot inten-
sity of which significantly increased with exposure time to
MMS. In contrast, the total amount of this protein was not
significantly changed over time similarly to the mRNA
expression level (Figure 3). In addition, GrcA (Synonyms:
YfiD) known to be induced by acid stress had also two iso-
forms (spots 12 and 13) on the 2-D gels. The response ten-
dency of the total level of this protein was similar to that
of the gene expression level (Figure 3). These results indi-
cate that MMS treatment triggers synthesis of some pro-
teins in different isoforms by posttranslational
modification.
As expected, 13 genes involved in DNA replication, repair
and modification (ada, alkB, dinD, mutS, polB, recN, rne,
sbmC, tpr, tus, umuD and uvrAB) were up-regulated to
allow prevention and repair of replication-blocking
lesions in E. coli cells exposed to alkylation stress. Among
these, the genes in the Ada regulon, ada and alkB were
strongly induced, which indicates that cells experiencing
DNA damage in response to MMS exposure try to mend
the damage by inducing the DNA repair system that is reg-
ulated by Ada. In addition to the Ada transcriptional reg-
ulator (ada), the expression of the genes encoding other
transcriptional regulators, such as the araC, kdpE, marA,
yadW, yafC, ybdO and ykgD genes, was significantly up-
regulated as seen in the 0.5 h transcriptome profiles. These
regulators might influence a dynamic network of the
adaptive response. The transcriptome experiments also
revealed that genes related to a variety of other cell proc-
esses, including chaperones (hscA and htpG), degradation
of small molecules (caiBDT), and adaptation and protec-
tion (betA, gef, htgA, ibpA and marA), were induced after
Growth profiles of E. coli W3110 (circle) and its ada mutant  (triangle) strains Figure 1
Growth profiles of E. coli W3110 (circle) and its ada 
mutant (triangle) strains. Each strain was cultivated with 
or without 0.04% MMS treatment (open or filled symbols, 
respectively) at the exponential phase (at 2.8 h; dotted line). 
Arrows indicate the sampling times (0.5, 1.5 and 3.9 h after 
MMS treatment) for transcriptome and proteome analyses.BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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MMS treatment. These responses are consistent with the
proteome data showing the induction of four proteins
(AhpF, HtpG, NfnB and YfiD) categorized into the adap-
tation and protection function. Induction of these pro-
teins seems to be involved in the protection of genes and/
or proteins against MMS toxicity.
In addition, a large number of genes with altered expres-
sion levels (356 up-regulated and 149 down-regulated)
was seen in 3.9 h profiles for E. coli W3110 cells (Figure
2). These mainly included genes involved in structure, cell
process and transport. These larger changes in the expres-
sion level might be due to the complicated response in the
stationary phase to alkylating agents. Previously, Sedg-
wick et al. [1] reported that the Ada regulon could be
induced during stationary phase and could protect against
active alkylators produced by nitrosation of amino acids
in non-growing cells. Therefore, an increase in expression
of the adaptive response genes, in parallel with expression
of the genes producing active alkylators during the sta-
tionary phase prevents alkylation damage to DNA and
subsequent mutagenesis.
Transcriptome and proteome profiles of the ada mutant 
strain in response to MMS
The transcriptional and translational responses of the ada
mutant strain to alkylation stress were vastly different
from those observed in W3110 strain (Figure 2). In the
ada mutant strain, the expression levels of many more
genes were significantly changed at 0.5 h after MMS treat-
ment; 932 genes were up-regulated, which was about
seven-fold more than that observed in the wild-type
strain. Also, 12 genes of known function were down-regu-
lated (Figure 2). The responses of the ada  mutant to
alkylating agents revealed several common themes,
including the activation of genes involved in the transport
of ions, sugars and amino acids and in detoxification
processes (Figure 4). This result indicates that the ada
mutant cells induce various genes related to influx or
efflux of solutes as a means of preventing and repairing
alkylation damage. However, unlike the wild-type cells, in
which these genes were up-regulated at 3.9 h after MMS
treatment, the expression of transport genes was down-
regulated in the ada mutant cells after the initial alkylation
stress was compensated. Based on these results, it can be
assumed that the transport system substitutes for the
adaptive response system in the ada mutant strain to coor-
dinate the instant activation of the cellular repair systems
after MMS treatment. More details are described below.
Proteome analysis showed variations in the production
levels of 21 protein spots; the spot intensities of 18 pro-
teins increased while 3 proteins decreased (Figure 3, Addi-
tional file 1: Table S1). Consistent with the transcriptome
data, the intensities of proteins involved in metabolism
and transport were increased. Proteins that showed signif-
icantly increased spot intensities in MMS-treated ada
mutant cells at 0.5 h included enzymes for DNA replica-
tion, recombination, modification and repair (RecA and
Mfd); cell process including adaptation and protection
(AhpF, CheA, HtpG and NfnB); translation and posttrans-
lational modification (RpsB, ThrS and an isoform of Tsf);
transport and binding proteins (DppA and OppA);
metabolisms (FabG, GlpA, PflB, PyrG (spot no. 42) and
TreC), and YeaG. Similar to proteome profiles of MMS-
treated wild-type cells, one isoform of elongation factor Ts
(Tsf) was detected on 2-D gels of MMS-treated ada cells.
Interestingly, the MMS treatment of the ada mutant cells
resulted in the significant repression of the FliC involved
in flagellar biosynthesis, which is consistent with down-
regulated expression of this gene in transcriptome data
(Additional file 1: Table S1).
In general, E. coli responds to alkylation stress by activat-
ing sets of co-regulated genes that help the cell to main-
tain homeostasis. However, the ada mutant cells would
require a more rapid increase in the expression levels of
specific genes for DNA repair in response to methylating
agents, due to the lack of the Ada-dependent response
mechanism. It can be seen from the 0.5 h profiles that the
adaptive response mediates the induction of 23 genes
involved in DNA replication, recombination, modifica-
tion and repair, such as b1360, dinD, lar, modF, mutH, ogt,
phrB, pinO, polB, priA, recANT, rnb, rnpA, ruvB, tpr, umuCD,
uvrA, yeeS, yfbL and yfjY. MMS treatment also caused a
strong induction of the drug or antibiotic resistance genes,
most of which are located in cell membrane (Figure 4,
Additional file 2). Proteome profiles also showed that
RcsB was increased in MMS-treated ada  mutant cells.
Taken together, the profiles for the ada  mutant strain
defective in adaptive response showed a far more rapid
transcriptional response following MMS treatment when
compared to the wild-type. From these results, we rea-
soned that the responses observed at earlier time point
might allow identification of direct targets of the adaptive
response, while the long-exposure time profiles would
reflect more complex regulation in cellular networks,
including both stationary phase responses by the rpoS
gene product [23,24] and adaptive response by alkylating
agents. Thus, the transcriptional and translational profiles
of the wild-type and the ada mutant strain at 0.5 h were
analyzed in more detail.
Differences in expression levels between wild-type and ada 
mutant strains under normal growth condition
In order to examine the intracellular changes that are
induced by the ada gene deletion in the MMS-untreated,
normal growth condition, the expression levels of genes
and proteins of ada mutant cells were first compared with
those of wild-type cells at the mid-log growth phase (atBMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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Distribution of differentially expressed genes Figure 2
Distribution of differentially expressed genes. E. coli W3110 (A) and its ada mutant (B) strains at each time profile (0.5, 
1.5 and 3.9 h) were sampled and compared after MMS treatment based on the corresponding untreated control. The up- or 
down-regulated genes at each time point were counted after classification by functional categories according to the E. coli 
genome information [22]. Categories: Structure, cell structure, membrane proteins, structural proteins; Transport, transport 
and binding proteins, putative transport proteins; Process, cell processes including adaptation and protection; DNA, DNA rep-
lication, recombination, modification and repair; Transcription, transcription, RNA processing and degradation; Translation, 
translation, post-translational modification; Energy, energy metabolism; Carbon, carbon compound catabolism; Amino acid, 
amino acid biosynthesis and metabolism; Nucleotide, nucleotide biosynthesis and metabolism; Fatty acid, fatty acid and phos-
pholipid metabolism; Intermediate, central intermediary metabolism; Regulation, regulatory function, putative regulatory pro-
teins; Cofactor, biosynthesis of cofactors, prosthetic groups and carriers; Phage, phage, transposon or plasmid. The number of 
total genes was indicated at the bottom of each heat map.BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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0.5 h sampling point). The number of genes differentially
expressed at greater than 2-fold levels was small. Only 69
and 10 genes were up- and down-regulated, respectively,
in the ada mutant strain compared to the wild-type strain
(Additional file 2). Interestingly, the expression levels of
the genes involved in flagellar biosynthesis (flgCEG and
fliAC) and chemotaxis (tar and cheW) were higher in the
ada mutant strain than in the wild-type. Proteome analy-
sis indicated 26 protein spots that were clearly affected in
the ada mutant cells, half of them being significantly over-
produced compared with the wild-type strain, while the
others being under-produced (Additional file 1: Table S1).
Eight proteins, including CheAY, FliC, GlnA, InfB, Mfd,
OsmY and PyrG (spot no. 42), were present only in the
ada mutant strain, while AnsB, GrcA (two spots), OppA
and PyrG (spot no. 4) were detected only in the wild-type
strain. Interestingly, the ada mutant cell showed a differ-
ent isoform distribution for CTP synthase (PyrG) com-
pared with that of the wild-type. This finding suggests that
the ada mutation alters this protein by posttranslational
modification.
Consistent with the transcriptome data, the main differ-
ences between the two strains were identified as the flag-
ellar biosynthesis protein (FliC) and chemotaxis proteins
(CheAY). These results indicate that Ada might be a nega-
tive regulator of bacterial chemotaxis under normal
growth condition. In addition, the small differences
between the strains suggest the limited role that Ada plays
under normal growth condition. In fact, there have been
no reports on any other functions of Ada except its adap-
tive response to protect cells from DNA damage by
alkylating agents [21]. However, our study indicates that
Ada plays an additional role as a transcriptional regulator
under normal growth condition and this can be a reason
why the final concentration of the ada mutant strain was
lower than that of the wild-type strain, as shown in Figure
1.
Expression levels of the genes in the Ada regulon
As mentioned previously, the adaptive response set of
genes is comprised of the ada, alkA, alkB and aidB genes
[7]. Expression of these genes is regulated by Ada, and
their induction provides protection against alkylation
damage to DNA. To validate the expression levels of these
genes in response to alkylation damage, we examined
their transcriptional levels in both E. coli W3110 and the
ada  mutant strains at three different time points after
MMS treatment, by both DNA microarray and real-time
PCR analyses (Figure 5). As expected, the results obtained
from real-time PCR analysis strongly correlated with those
from DNA microarray analysis (r2 = 0.90). The expression
levels of the genes in wild-type and mutant strains were
obviously different in MMS-treated condition. However,
they were not significantly changed over time in the ada
mutant strain, compared with those of its parent strain.
On the other hand, the alkA and related genes showed
gradually increased or decreased expression levels over the
time in the wild-type and mutant strains, respectively.
This implies that the adaptive response resulting from the
up-regulation of these genes was not induced in the
absence of the ada gene. This finding is in good agreement
with previous reports showing that the expression of these
four genes is positively controlled by Ada only after it
interacts with methylated DNA [11-14].
The expression profiles of genes involved in the adaptive
response of E. coli could be divided into two groups:
namely, ada-like or alkA-like expression profiles. The ada-
like expressed genes including the ada, alkB and aidB genes
showed the highest expression levels relatively early after
MMS addition (at 0.5 h and 1.5 h profiles) and decreased
later. On the other hand, the alkA-like expressed genes,
such as the alkA gene, presented a gradually increased
expression level over the time. A previous study showed
that the ada and alkA genes are regulated by a distinct
mechanism in response to alkylation damage [21], and
this is supported by our data. However, the differences in
the expression levels of the four genes (ada, alkA, alkB and
aidB) between the wild-type and ada mutant strains were
negligible under normal condition (data not shown),
which suggests that this adaptive response might reflect an
inducible mechanism that generates genetic variability in
times of alkylation stress.
Increased expression levels of the genes and proteins 
involved in flagellar biosynthesis and chemotaxis
The synthesis and proper functioning of the flagellar and
chemotaxis system require the expression of more than 50
genes, which are divided among at least 17 operons con-
stituting the large, coordinately regulated flagellar regulon
[25]. As described above, even under normal growth con-
dition, the expression levels of the genes belonging to this
group were increased in the ada mutant strain compared
to the wild-type strain, and were further increased at 0.5 h
following MMS treatment. The key master regulator,
encoded by flhCD, was moderately increased in the ada
mutant cells at 0.5 h after MMS treatment and five addi-
tional flagellar biosynthesis genes (flgAH, flhB and fliST)
were also up-regulated. Four genes involved in the chem-
otaxis signal transduction system were up-regulated
including the genes for three chemoreceptors (aer, tar and
trg) and the CheA kinase (cheA), which activates the CheY
response regulator via phosphorylation and then influ-
ences flagellum activity through interaction with the
motor. These findings also agree with proteomic data that
showed that enzymes of chemotaxis (CheAY) and flagel-
lar biosynthesis (FliC) were detected only in the ada
mutant strain (Figure 3, Additional file 1: Table S1). These
chemotaxis genes are not directly regulated by FlhDC, butBMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
Page 7 of 13
(page number not for citation purposes)
Proteome and transcriptome profiles of E. coli W3110 (A) and its ada mutant (B) strains Figure 3
Proteome and transcriptome profiles of E. coli W3110 (A) and its ada mutant (B) strains. The proteins showing 
significantly altered levels according to exposure time of MMS are indicated on each 2-D gel as circles when samples taken 
from MMS-treated cells were compared to the corresponding untreated control. Of these, seventeen zoomed in areas high-
lighted from the 0 h profile gel of each strain are compared to corresponding protein spots of the 0.5, 1.5 and 3.9 h profile gels 
with (+) or without (-) MMS addition. Also, the fold difference (log2 scale) of expression level of the corresponding genes of E. 
coli W3110 (A) and ada mutant strains (B) under MMS-treated and -untreated conditions are shown next to the panels of pro-
teome spots.BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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are controlled by the flagellum sigma factor, σF, encoded
by fliA. However, the expression of fliA was not signifi-
cantly changed with time in the ada  mutant cells,
although the fliAYZ operon is regulated by FlhCD. The
protein kinase, CheA, plays a central role in the initial
excitation responses to stimuli as well as in the subse-
quent events associated with adaptation. The activity of
the CheA kinase is increased by the increased levels of
receptor methylation [26]. High levels of receptor methyl-
ation have been correlated with tumbly behavior, provid-
ing evidence that changes in receptor methylation
mediate adaptive responses to attractant and repellent
stimuli. Thus, the increased expression of these genes is
closely related to negative Ada-dependent regulation in E.
coli and Ada might negatively affect the protein compo-
nents of bacterial chemotaxis. The flagellar biosynthesis
genes and chemotaxis genes seem to contribute to protect-
ing the viability of ada mutant cells by transferring methyl
Schematic diagram of up-regulated genes in the MMS-treated E. coli ada mutant strain Figure 4
Schematic diagram of up-regulated genes in the MMS-treated E. coli ada mutant strain. The two-component sys-
tem related to drug or antibiotic resistance and the operons of genes related to respiration and transport are shown. The 
genes up-regulated more than 2-fold by 0.5 h MMS treatment, based on the corresponding untreated control in the ada mutant 
strain, are indicated in black bold type.BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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group to methyl-accepting proteins (MCP) such as Aer,
Tar and Trg.
Increased expression levels of the genes and proteins 
related to drugs or antibiotics resistance
The ada mutant cells that are hypersensitive to alkylating
agents compared to wild-type cells might need to activate
the expression of drug or antibiotic resistance genes to
reduce their susceptibility to alkylation damage. In fact,
many genes involved in these functions were found to be
induced, some rapidly and some later in response to MMS
treatment (Figure 4). The expression level of the fsr gene
responsible for fosmidomycin resistance was rapidly and
continuously induced in both strains after MMS treat-
ment, and this gene also showed increased expression in
the ada mutant strain compared to the wild-type under
normal growth condition. Additionally, genes encoding
the multiple antibiotic resistance protein (marABR),
microcin B17 uptake protein (sbmA), and putative resist-
ance protein (ydeA) were also up-regulated in both strains
at 3.9 h post MMS treatment, in the stationary phase. This
observation is consistent with the fact that the Ada regu-
lon is highly induced during the stationary phase [24] and
that it protects cells from active alkylators produced by
nitrosation of amino acids [1,2]. However, some of genes
belonging to this function showed different expression
patterns between the strains. For example, the genes
encoding multidrug resistance proteins (emrABDE) were
rapidly induced at 0.5 h profile in the ada mutant strain
and decreased afterwards. On the other hand, some of
these genes (emrBEY) were increased later at 3.9 h profile
only in the wild-type strain. This result suggests that the
ada mutant strain might require a timely and rapid induc-
tion of the drug or antibiotic resistance genes to reduce its
susceptibility to alkylation damage. Proteome data also
showed induction of proteins related to detoxification
(AhpF and NfnB) in both strains following MMS treat-
ment. Alkylating agents that target DNA-associated proc-
esses are anticipated to be far more specific and effective
as antibiotics or drugs [3-5]. This seems to be why the drug
or antibiotics resistance genes were expressed upon MMS
treatment. In addition, it has been demonstrated that
DNA repair is enhanced in drug-resistant cell lines and
tumors [3]. These results indicate that the expression of
drug or antibiotic resistance genes might be affected in the
DNA repair processes.
In addition, proteome analysis indicated that RcsB
responded to peptidoglycan damage and contributed to
intrinsic antibiotic resistance of E. coli [27] was synthe-
sized at high level in the ada mutant strain. The finding
allowed us to further examine the changes of the expres-
sion levels of drug or antibiotic resistance genes from tran-
scriptome profiles. Hirakawa et al. [28] demonstrated that
overexpression of fifteen genes, baeR,  citB,  cpxR,  evgA,
fimZ, kdpE, narLP, ompR, rcsB, rstA, torR, yedW, yehT and
dcuR, which are response regulators of two-component
signal transduction systems in E. coli, conferred increased
The expression levels of the Ada regulon Figure 5
The expression levels of the Ada regulon. The expression levels of the ada, aidB, alkA and alkB genes of E. coli W3110 (A) 
and its ada mutant (B) strains at each time profile (0.5, 1.5 and 3.9 h) after MMS treatment were revealed by DNA microarray 
(chip) and real-time PCR (RT) analyses, compared to the corresponding untreated control. The real-time PCR experiments 
were conducted at least three times with independently isolated RNA sample.BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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single- or multidrug resistance. Interestingly, as shown in
Figure 4, most of these genes, including the baeR, citB,
cpxR, evgA, fimZ, ompR, rcsB, rstA and yedW genes, were up-
regulated in the ada mutant strain at 0.5 h after MMS treat-
ment. Expression of the cognate sensor gene of two-com-
ponent transduction systems (baeRS, citAB, cpxAR, evgAS
and rstAB, but not yedVW) increased coordinately when it
was cotranscribed with the regulator. Increased expression
levels were also observed when the sensor was even in a
separate operon (fimZ-ampC and ompR-envZ). However,
no induction of these two-component transduction genes
was observed in MMS-treated wild-type strain. These find-
ings show that the up-regulated genes of the bacterial two-
component signal transduction systems might confer
MMS resistance in the absence of the ada gene, through
the control of the expression of drug or antibiotic trans-
porter genes [29,30]. This type of response regulator-
mediated drug resistance might be required for acquiring
MMS toxicity resistance although the mechanism of the
response is not yet clear. Furthermore, this is closely cor-
related with the finding that increased expression levels of
the genes involved in transport systems are seen in the 0.5
h profile of the ada mutant strain (Figure 4). The influx
and efflux of solutes through the cell might also play a
major role in intrinsic tolerance of bacteria to drugs and
toxic compounds as adaptive responses.
Induction of DNA repair mechanisms
The prevention of the mutagenic and lethal consequences
of DNA damage requires the timely expression of DNA
repair and protective genes, in order to maintain the integ-
rity of the genome and viability of the cell. As pointed out
before, Ada is an important transcriptional regulator in
addition to having a direct role as a methyl acceptor dur-
ing DNA repair. Thus, the up-regulated expression of the
ada gene positively affects cell adaptation of alkylation
damage by MMS in E. coli W3110 strain. The high level of
ada expression, together with high level of 3-methylade-
nine-DNA glycosylase (encoded by the alkA gene), might
be sufficient to repair these lesions, making high-level
expression of the aidB and alkB genes unnecessary at 0.5 h
after MMS treatment. This coordinated expression of the
alkA and ada genes is noteworthy in that the two gene
products repair different types of alkylation damage by
different mechanisms, as illustrated [21]. The linked regu-
lation of these two proteins thus optimizes the repair of
several diverse lesions that are likely to be formed in DNA
by a single alkylating agent. However, it can be postulated
that ada mutant strain express higher amounts of other
genes involved in DNA repair systems, as well as two dif-
ferent 3-methyladenine-DNA glycosylases (tag and alkA)
in order to compensate for its function. Recent studies
have demonstrated the presence of a second DNA repair
methyltransferase, encoded by the ogt gene, for the direct
repair of alkylating lesions in E. coli, in which the ada gene
has been inactivated by mutation [31]. This was consist-
ent with our observation that the expression of the ogt
gene was highly up-regulated at 0.5 h in the MMS-treated
ada mutant cells, showing that the ogt gene is required for
cell adaptation in the absence of the ada gene. In addition,
the expression of the alkB gene continually increased in
MMS-treated ada mutant strain, revealing that these genes
can trigger the adaptive response to alkylating agents in
the ada mutant strain.
Another reaction that operates by the direct reversal of
damage in the DNA of the ada mutant strain at 0.5 h is
that of the DNA photolyase, encoded by the phrB gene
[32]. Other up-regulated genes and proteins involved in
DNA repair [24] at 0.5 h in the ada mutant strain are
endonuclease III and VIII (nth); exonulease III (xthA);
endonuclease IV (nfo); mismatch repair (vsr and mutHL);
cleaning of precursor pool (mutT); nucleotide excision
repair (uvrABCD, and mfd); and post-replication repair,
SOS regulation and translesion synthesis (recA, lexA and
umuDC). Moreover, redox control of transcription (soxRS)
and DNA ligase (lig) were moderately increased at 0.5 h in
the ada mutant strain. Proteome analysis also indicated
that RecA was significantly increased in the wild-type
strain after MMS treatment and decreased afterwards. On
the other hand, it was relatively rapidly and continually
increased in the ada mutant strain after MMS treatment.
These results indicate that the adaptive response is regu-
lated partially by the SOS response, a complex, graded
response to DNA damage that includes timely induction
of gene products that block cell division and others that
promote mutation, recombination and DNA repair. How-
ever, it has been reported that the adaptive response is dis-
tinct from previously characterized pathways of DNA
repair, particularly from the SOS response [8,33]. These
findings indicated that the adaptation did not lead to
expression of SOS functions, since the recA and lexA
mutant cells that were unable to perform SOS repair could
be adapted to alkylating agents, such as MNNG [8,33].
This is inconsistent with our result that showed high
expression levels of genes involved in SOS response in the
MMS-treated wild-type and ada  mutant strains. Their
expression levels in the ada mutant strain were the higher
than the wild-type strain.
The up-regulated LexA regulon included DNA recombina-
tion and repair genes (recAN and ruvAB), nucleotide exci-
sion repair genes (uvrABD), the error-prone DNA
polymerase genes (umuDC) and DNA polymerase II gene
(polB). Continued up-regulation of the LexA regulon sug-
gests that blockage of DNA replication and/or DNA dam-
age persists, leading to SOS signaling. These results
indicate that SOS-induced levels of these gene products
are needed for the adaptive response caused by MMS. In
particular, other SOS-inducible gene products areBMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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required for efficient adaptive response in the absence of
the ada gene to compensate for its role. For example, it
was evident that DNA damage caused by MMS led to a sig-
nificant induction of the dnaNQ gene expression [34],
suggesting a requirement for increased amounts of at least
some DNA polymerase III holoenzyme subunits for
recovery from the DNA damage caused by MMS. Our
results are in agreement with the other findings and addi-
tionally show that enhanced amounts of at least some
subunits of the DNA polymerase III holoenzyme (dnaNT)
might be necessary to repair DNA damage caused by
MMS. The up-regulated DNA biosynthesis-related genes
included the genes for chromosome replication (dnaC)
and DNA primase (dnaG). However, these genes did not
increase in MMS-treated wild-type cells. This result sug-
gests that increased amounts of at least some subunits of
DNA polymerase III holoenzyme are required for repair
and recovery of MMS induced DNA damage, in agreement
with the small number of polymerase molecules per cell.
Taken together, the increase in expression of these genes
seems to be connected to the SOS response, and provides
evidence that the adaptive response is a timely response
that is tightly regulated in a coordinated fashion, through
both positive and negative control by the SOS and other
DNA repair systems. Interestingly, the adaptation of the
ada mutant strain appears to occur within a narrow win-
dow in response to the level of SOS induction.
Conclusion
E. coli responds to alkylation stress by activating sets of co-
regulated genes that help the cell to maintain homeosta-
sis. Overall, the transcriptional and translational
responses of the ada mutant strain by alkylation damage
are similar to those of the wild-type strain, but some dif-
ferences between the strains were observed within a nar-
row window following MMS treatment. The ada mutant
strain showed that the adaptive response mediated a
strong induction of many genes involved in DNA replica-
tion, recombination, modification and repair. This indi-
cates that the adaptive response in the ada mutant strain
by MMS treatment is a tightly regulated response that
functions in a timely and coordinated fashion and is con-
trolled both positively and negatively by the SOS and
other DNA repair systems. Secondary effects of increased
expression of drug or antibiotic resistance genes were
observed with up-regulation of many transporter-related
operons for acquiring MMS toxicity resistance. An addi-
tional interesting observation is that the ada  mutation
resulted in derepression of bacterial chemotaxis and flag-
ellar synthesis, which suggests an additional role of Ada as
a negative transcriptional regulator for the expression of
the genes involved in chemotaxis and flagellar synthesis,
although the Ada regulator might have only a limited
influence on cellular physiology under normal growth
condition.
Methods
Bacterial strains
E. coli W3110 (derived from K-12, λ-, F-, prototrophic)
and its ada mutant (WA; W3110ada::Kmr) strains were
used in this study. The mutant strain was constructed by
disrupting the ada  gene in the chromosome of E. coli
W3110 by a homologous recombination system using λ
Red recombinase [35].
Culture conditions and MMS treatment
Cells were cultivated at 37°C and 250 rpm in 100 mL of
Luria-Bertani (LB) medium (10 g/L tryptone, 5 g/L yeast
extract, and 5 g/L NaCl) in 250-mL Erlenmeyer flasks.
Cells grown for 15 h were diluted 1:100 in fresh LB
medium and further cultured to an optical density at 600
nm (OD600) of 0.4. Methyl methanesulfonate (MMS;
Sigma-Aldrich, St. Louis, MO, USA) was added to 0.04%
v/v [20], and cells were collected at predetermined sam-
pling times (0.5, 1.5 and 3.9 h) for the analyses of tran-
scriptome and proteome. For comparison, both strains
were also grown without MMS addition as controls. Cell
growth was monitored by measuring the OD600 using a
spectrophotometer (Ultraspec3000; Pharmacia Biotech,
Uppsala, Sweden). When required, ampicillin (50 μg/mL)
and/or kanamycin (35 μg/mL) were supplemented.
DNA microarray analysis
All procedures including RNA preparation, cDNA labe-
ling, DNA hybridization and data analysis were carried
out as described previously [36]. GenePlorer TwinChip E.
coli-6 K oligo chips (GT3001; Digital Genomics, Seoul,
Korea) were used according to the manufacturer's proto-
col. The microarray images were obtained using the Axon
Scanner (Axon, Inc., Union City, CA, USA), and analyzed
using the GenePix 3.0 (Axon) and Genesis 1.5.0. beta 1
http://genome.tugraz.at softwares. Briefly, the signal
intensities higher than the mean background intensities
by 3-fold greater than the overall standard deviation were
chosen. Global normalization was carried out by dividing
each of fluorescence intensities by their sums. The expres-
sion level of each gene was normalized to the variance of
1. Duplicate replicates were carried out. DNA microarray
data are available in Additional file 2. All DNA microarray
data were also deposited in Gene Expression Omnibus
(GEO) database (GSE16565).
Real-time PCR analysis
Real-time PCR analysis was performed as described previ-
ously [36] with the iCycler iQ real-time PCR detection sys-
tem (Bio-Rad) using the iQ SYBR Green Supermix (Bio-
Rad). The rrsB gene was used as a reference gene for nor-
malization, and the data were analyzed using the 2-ΔΔC
T
method [37]. The amplicons were obtained using the fol-
lowing primer sets.
ada-for (5'-GAAACGCCTGTAACGCTGG-3')BMC Microbiology 2009, 9:186 http://www.biomedcentral.com/1471-2180/9/186
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ada-rev (5'-GGCTTTAGGCGTCATTCCG-3')
alkA-for (5'-TGGCGAACGGCTGGATGATT-3')
alkA-rev (5'-TTCAACGGCATACCTAACGCTTT-3')
alkB-for (5'-GCCCATTGATCCGCAAAC-3')
alkB-rev (5'-CTGGAAATCTGGATAGCCCG-3')
aidB-for (5'-GAACGGCTGAATCCCTTGAACTG-3')
aidB-rev (5'-TGAAAACGCACATCG TCCAGAC-3')
Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis (2-DE) experiments
were performed using the IPGphor IEF system (GE
Healthcare Life Sciences, Chalfont St. Giles, UK) and Pro-
tean II xi Cell (Bio-Rad, Hercules, CA, USA) as described
previously [38]. Cell extracts were obtained as reported
previously [39]. The protein samples (200 μg) were
applied to the Immobiline DryStrips (18 cm, pH 3-10 NL;
GE Healthcare) using in-gel rehydration in an IPGphor
(GE Healthcare) using five phases of stepped voltages
from 200 to 8000 V with total focusing of 60 kV·h. The
strips were then placed on 12% w/v SDS-PAGE gels pre-
pared by the standard protocol [40]. Protein spots were
visualized using a silver staining kit (GE Healthcare) and
the stained gels were scanned by a UMAX PowerLook
2100XL Scanner (UMAX Technologies, Inc., TX, USA).
PDQuest 2-D Analysis Software (Bio-Rad) was used to
automate the process of finding protein spots within the
image and to quantify the density of the spots on a per-
centage of volume basis. Features resulting from non-pro-
tein sources (e.g. dust particles and scratches) were filtered
out and protein spots were normalized and pairwise
image comparisons were performed. At least triplicate gels
of each sample were analyzed. All protein spots exhibiting
at least 2-fold differences between the samples were eval-
uated for statistical significance using the Student's t-test
and all spots with p values of < 0.05 were matched with
the corresponding spots on the silver stained images for
identification using LC-MS/MS.
LC-MS/MS and data analysis
For protein identification by the MS/MS analysis, samples
were prepared as described previously [41]. Tryptic pep-
tides (10 μL aliquots) were analyzed by a nano-LC/MS
system consisting of an Ultimate HPLC system (LC Pack-
ings, Amsterdam, Netherlands) and a quadrupole-time-
of-flight (Q-TOF) MS (Micromass, Manchester, UK)
equipped with a nano-ESI source as described previously
[39]. The MASCOT search server (version 1.8; http://
www.matrixscience.com/) was used for the identification
of protein spots by querying sequence of the trypsin
digested peptide fragment data. Reference databases used
for the identification of target proteins were UniProt
Knowledgebase (Swiss-Prot and TrEMBL; http://
kr.expasy.org/) and NCBI http://www.ncbi.nlm.nih.gov/.
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